Wanbury (WANBURY) | Stock Overview & Key Data
Wanbury Performance Comparison
Stock Range
Today's Range
Low: ₹283.25
High: ₹301.35
on August 22, 2025
52 Week Range
Low: ₹154.01
High: ₹329.70
on March 3, 2025
on May 16, 2025
All-Time High: ₹329.70 on May 12, 2025
Explore how other Indian stocks compare to their 52-week ranges: View IN Market 52-Week Insights
Key Statistics
Market Cap
INR9.2B
EPS
12.62
P/E Ratio (TTM)
22.21
Forward P/E
N/A
P/B Ratio
15.50
PEG Ratio
0.02
Div. Yield
N/A
ROE
51.51%
Beta
0.187
Debt to Equity
298.48
Financial Highlights
Profitability
Gross Margin
53.83%
Operating Margin
12.75%
Profit Margin
6.81%
Returns and Earnings
Return on Assets (TTM)
7.38%
Return on Equity (TTM)
51.51%
EBITDA
INR926.8M
Net Income (TTM)
INR429.8M
Growth
Revenue (TTM)
Revenue Per Share (TTM)
INR192.73
Quarterly Revenue Growth (YoY)
24.50%
Quarterly Earnings Growth (YoY)
1,200.40%
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| Wanbury WANBURY | 9.22B Small-cap | 15.86% | 14.47% | 3.72% | 51.64% | 1.74% | 37.78% | 407.32% | 670.72% |
| Sun Pharmaceutical SUNPHARMA | 3.92T Large-cap | 0.56% | -2.16% | -4.47% | 0.14% | -13.13% | -7.54% | 86.54% | 195.42% |
| Divi's Laboratories DIVISLAB | 1.63T Large-cap | -0.21% | -6.98% | -5.91% | 7.87% | 1.29% | 26.68% | 71.47% | 87.96% |
| Sun Pharma Advanced SPARC | 47.77B Small-cap | 1.72% | -7.23% | -10.11% | 14.74% | -27.21% | -34.43% | -37.13% | -23.18% |
| Aarti Drugs AARTIDRUGS | 42.99B Small-cap | -4.13% | -10.00% | 1.76% | 27.10% | 6.05% | -14.34% | 10.27% | -34.08% |
| Sequent Scientific SEQUENT | 44.30B Small-cap | 0.12% | -6.92% | -2.35% | 12.64% | -4.77% | 5.41% | 52.52% | 30.60% |
Ownership & Short Interest
Insider Ownership
48.17%
Institutional Ownership
3.62%
Shares Short
N/A
Short Ratio
N/A
Short % of Shares Outstanding
N/A
Average 10-Day Volume
49K
Average 90-Day Volume
50K
Wanbury Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in Wanbury would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is WANBURY's 52-week high and low?
- In the last 52 weeks, Wanbury reached a high of ₹329.70 (on May 16, 2025) and a low of ₹154.01 (on March 3, 2025).
- What is the market cap and P/E ratio for WANBURY?
- Curious about Wanbury's size and valuation? Its market capitalization stands at 9.22B. When it comes to valuation, the P/E ratio (trailing twelve months) is 22.21, and the forward P/E (looking ahead) is N/A.
- Does WANBURY pay dividends? If so, what's the yield?
- As for dividends, Wanbury isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are Wanbury's main competitors or similar companies to consider before investing?
When looking at Wanbury, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Sun Pharmaceutical
SUNPHARMA3.92T Healthcare Drug Manufacturers - Specialty & Generic -7.54% 86.54% Divi's Laboratories
DIVISLAB1.63T Healthcare Drug Manufacturers - Specialty & Generic 26.68% 71.47% Sun Pharma Advanced
SPARC47.77B Healthcare Drug Manufacturers - Specialty & Generic -34.43% -37.13% Aarti Drugs
AARTIDRUGS42.99B Healthcare Drug Manufacturers - Specialty & Generic -14.34% 10.27% Sequent Scientific
SEQUENT44.30B Healthcare Drug Manufacturers - Specialty & Generic 5.41% 52.52% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Wanbury Ltd.? (e.g., ROE, Debt/Equity)
- To get a sense of Wanbury's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 51.51%, the Debt to Equity ratio from the most recent quarter is 298.48, and its Gross Profit Margin stands at 53.83%.
- What is the recent revenue and earnings growth for WANBURY?
- Looking at Wanbury's growth, its revenue over the trailing twelve months (TTM) was INR6B. Compared to the same quarter last year (YoY), quarterly revenue grew by 24.50%, and quarterly earnings saw a YoY growth of 1,200.40%.
- How much of WANBURY stock is held by insiders and institutions?
- Wondering who owns Wanbury stock? Company insiders (like executives and directors) hold about 48.17% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 3.62%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.